UGONMA NWOKORIE: Open Payments
NPI 1154091767 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 10 payments from 6 companies in 2025. Trend: 2023 $58 · 2024 $40 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Indivior Inc. | 1 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, REXULTI, SUBLOCADE, Qelbree, VRAYLAR, MOUNJARO.
Industry payments across MD — which companies pay providers there.
